|By Marketwired .||
|August 25, 2014 07:30 AM EDT||
ATLANTA, GA and WARSAW, POLAND--(Marketwired - August 25, 2014) - Perma-Fix Medical S.A. (WAR: PFM), a subsidiary of Perma-Fix Environmental Services, Inc. (NASDAQ: PESI), and developer of a reliable, cost effective, non-uranium process to produce technetium-99 (Tc-99m), the most widely used medical isotope in the world, announces that Dr. Louis F. Centofanti, of Perma-Fix Medical, will present at the 8th International Conference on Isotopes (8ICI) and Expo today, Monday August 25, 2014 at 1PM Central Time. Dr. Centofanti will provide a detailed discussion of the company's new process to produce Tc-99m which does not involve the use of uranium.
The ICI conferences is organized by the World Council on Isotopes and hosted by the American Nuclear Society. The conference highlights the importance of nuclear science, medicine and technology in advancing human health and protection of the environment. Delegates from around the world-nuclear and medical physicists, radiochemists, engineers, material scientists, physicians, health physicists and specialists in non-proliferation-will come together in Chicago, Illinois, to discuss current and future research in the field of isotopes. The conference will build on past conferences by continuing a multifaceted interdisciplinary exchange between the developers and producers of isotopes, and the researchers who develop and apply isotopes in medicine, industry, agriculture, national security and other fields.
Dr. Louis F. Centofanti, CEO of Perma-Fix Medical, commented, "We are honored to present at this important international conference. We look forward to discussing our technology with industry leaders, including how our process can improve the supply chain and address prevailing concerns about supply shortages for Tc-99m. Importantly, our process does not use uranium and can be performed in most standard commercial or research reactors. We continue moving forward with our plans to commercialize the technology in both the U.S. and Europe and look forward to announcing additional milestones in the near future."
About Perma-Fix Medical
Perma-Fix Medical was formed to develop, obtain FDA and other regulatory approval and commercialize a new process to produce Technetium-99 (Tc-99m), the most widely used medical isotope in the world. The new process is expected to solve worldwide shortages of Tc-99m as it is less expensive, does not require the use of government-subsidized, weapons-grade materials and can be easily deployed around the world using standard research and commercial reactors, thereby eliminating the need for special purpose reactors.
Please visit us on the World Wide Web at http://www.medical-isotope.com.
David K. Waldman
Crescendo Communications Europe S.A.
Tel : +1-212-671-1021
Email : [email protected]
Jul. 30, 2016 04:30 PM EDT Reads: 2,264
Jul. 30, 2016 04:30 PM EDT Reads: 537
Jul. 30, 2016 04:30 PM EDT Reads: 1,104
Jul. 30, 2016 04:15 PM EDT Reads: 605
Jul. 30, 2016 02:30 PM EDT Reads: 1,054
Jul. 30, 2016 02:00 PM EDT Reads: 511
Jul. 30, 2016 01:30 PM EDT Reads: 969
Jul. 30, 2016 01:00 PM EDT Reads: 1,854
Jul. 30, 2016 01:00 PM EDT Reads: 2,122
Jul. 30, 2016 12:00 PM EDT Reads: 1,360
Jul. 30, 2016 11:30 AM EDT Reads: 1,400
Jul. 30, 2016 11:00 AM EDT Reads: 629
Jul. 30, 2016 11:00 AM EDT Reads: 542
Jul. 30, 2016 10:45 AM EDT Reads: 1,110
SYS-CON Events announced today the Kubernetes and Google Container Engine Workshop, being held November 3, 2016, in conjunction with @DevOpsSummit at 19th Cloud Expo at the Santa Clara Convention Center in Santa Clara, CA. This workshop led by Sebastian Scheele introduces participants to Kubernetes and Google Container Engine (GKE). Through a combination of instructor-led presentations, demonstrations, and hands-on labs, students learn the key concepts and practices for deploying and maintainin...
Jul. 30, 2016 10:15 AM EDT Reads: 1,048